Marc M. P. de Garidel
Chief Executive Officer at CINCOR PHARMA, INC.
Net worth: 17 M $ as of 2024-03-30
Network origin in Marc M. P. de Garidel first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
294
| Public Company | Pharmaceuticals: Major | 294 |
| Public Company | Pharmaceuticals: Major | 117 | |
72
| Public Company | Pharmaceuticals: Major | 72 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.
32
| Non-Profit Organization | Miscellaneous Commercial Services | 32 |
| Subsidiary | Pharmaceuticals: Major | 17 | |
17
| Public Company | Pharmaceuticals: Other | 17 |
12
| Extinct | Pharmaceuticals: Major | 12 |
ESSEC Business School
10
| College/University | Other Consumer Services | 10 |
ESCP Europe Campus Paris
6
| College/University | Other Consumer Services | 6 |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.
5
| Subsidiary | Biotechnology | 5 |
Claris Biotherapeutics, Inc.
 Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ.
4
| Holding Company | Pharmaceuticals: Major | 4 |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Leem
1
| Non-Profit Organization | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marc M. P. de Garidel via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing Chief Executive Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director of Finance/CFO President | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal Director/Board Member President Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| UCB | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Esaote SpA
 Esaote SpA Medical SpecialtiesHealth Technology Esaote SpA is a holding company, which engages in the production of medical diagnostic systems. Its products include ultrasound system applications, dedicated magnetic resonance imaging (MRI) systems, healthcare information technology software applications, and interventional and mini-invasive system applications under the brand name Esaote. The company was founded by Carlo Castellano in 1982 and is headquartered in Genoa, Italy. | Medical Specialties | Director/Board Member Director/Board Member | |
| STALLERGENES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Chief Executive Officer | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ipsen Pharma SA
 Ipsen Pharma SA Pharmaceuticals: MajorHealth Technology Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain. | Pharmaceuticals: Major | President Chief Executive Officer Director/Board Member Director of Finance/CFO | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Chairman Director/Board Member Corporate Officer/Principal | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| EPIZYME, INC. | Biotechnology | Director/Board Member Director/Board Member President | |
Campus Holding SA
 Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| The European Association for Bioindustries | Director/Board Member Corporate Officer/Principal | ||
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chairman Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact President | |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Chief Executive Officer Chairman Chairman Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Graduate Degree | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member President | |
| STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 23 |
| France | 13 |
| Switzerland | 6 |
| Belgium | 3 |
| Germany | 2 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 4 |
Operational
| Director/Board Member | 634 |
| Corporate Officer/Principal | 248 |
| Independent Dir/Board Member | 160 |
| Chairman | 114 |
| Chief Executive Officer | 106 |
Most connected contacts
| Insiders | |
|---|---|
| Philippe Pouletty | 51 |
| James Healy | 50 |
| Jean-Luc Bélingard | 40 |
| Carol Gallagher | 39 |
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Michèle Ollier | 33 |
| Kathryn Falberg | 30 |
| Dennis Fenton | 28 |
| Rolf K. Hoffmann | 27 |
| David Baltimore | 27 |
| Michael Davidson | 27 |
| Carol Brosgart | 25 |
| Stefan Oschmann | 23 |
| Jacques Theurillat | 22 |
| Diana McKenzie | 21 |
- Stock Market
- Insiders
- Marc M. P. de Garidel
- Company connections
